Tag Archives: Theralugand®

Eckert & Ziegler’s Theralugand® Gains EU Approval for Advanced Cancer Therapies

Posted on 27, November 2024 by

(IN BRIEF) The European Commission has approved Theralugand®, Eckert & Ziegler’s high-purity Lutetium-177 chloride, for routine clinical use across the European Economic Area. This approval allows its application in targeted cancer therapies, such as for neuroendocrine tumors and metastatic prostate … Read the full press release →

Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology

Tagged , , , , , , ,